Effect of Pravastatin on Outcomes after Cardiac Transplantation

19951,301 citationsJournal Articlebronze Open Access

Authors

Jon Kobashigawa · University of California, Los Angeles

S Katznelson · University of California, Los Angeles

Hillel Laks · University of California, Los Angeles

Jay A. Johnson · University of California, Los Angeles

Lawrence A. Yeatman · University of California, Los Angeles

Xiu Ming Wang · University of California, Los Angeles

David Chia

Abstract

After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, and the incidence of coronary vasculopathy.

Topics & Keywords

Transplantation: Methods and Outcomes Viral Infections and Immunology Research Organ Transplantation Techniques and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 333, Issue 10, pp. 621-627

DOI: 10.1056/nejm199509073331003

Field-Weighted Citation Impact: 47.37